Free Trial

Inspire Investing LLC Decreases Stake in Genpact Limited $G

Genpact logo with Computer and Technology background

Key Points

  • Inspire Investing LLC reduced its stake in Genpact Limited by 17.0% in the 1st quarter, selling 5,894 shares to hold 28,798 shares valued at approximately $1,451,000.
  • Analyst ratings have varied, with Wall Street Zen downgrading Genpact from a "buy" to a "hold" while Needham & Company raised its price target from $50 to $53.
  • Genpact recently announced a quarterly dividend of $0.17 per share, representing an annualized yield of 1.6%.
  • Five stocks to consider instead of Genpact.

Inspire Investing LLC reduced its stake in Genpact Limited (NYSE:G - Free Report) by 17.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,798 shares of the business services provider's stock after selling 5,894 shares during the period. Inspire Investing LLC's holdings in Genpact were worth $1,451,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of G. Sumitomo Mitsui Trust Group Inc. purchased a new position in Genpact in the 1st quarter worth approximately $115,807,000. Clark Capital Management Group Inc. purchased a new position in Genpact in the 1st quarter worth approximately $64,842,000. Millennium Management LLC increased its stake in Genpact by 829.4% in the 4th quarter. Millennium Management LLC now owns 1,057,389 shares of the business services provider's stock worth $45,415,000 after purchasing an additional 943,622 shares during the period. Ameriprise Financial Inc. increased its stake in Genpact by 109.8% in the 1st quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider's stock worth $81,375,000 after purchasing an additional 845,393 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Genpact by 20.9% in the 1st quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider's stock worth $207,129,000 after purchasing an additional 710,704 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.

Genpact Stock Down 1.0%

Shares of NYSE G traded down $0.41 during mid-day trading on Monday, hitting $42.11. 1,521,112 shares of the stock traded hands, compared to its average volume of 1,686,304. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. Genpact Limited has a 52 week low of $37.82 and a 52 week high of $56.76. The company has a market cap of $7.34 billion, a price-to-earnings ratio of 13.99, a PEG ratio of 1.46 and a beta of 0.92. The stock has a fifty day moving average price of $44.37 and a 200-day moving average price of $45.74.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The company had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the previous year, the company posted $0.79 earnings per share. The firm's revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Research analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's payout ratio is 22.59%.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of the business's stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total value of $2,384,800.00. Following the sale, the chief executive officer directly owned 295,246 shares of the company's stock, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Piyush Mehta sold 76,902 shares of the business's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the sale, the senior vice president directly owned 134,880 shares in the company, valued at $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have commented on G. Needham & Company LLC lifted their price target on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Mizuho lifted their price objective on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. JPMorgan Chase & Co. cut their price objective on Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $52.29.

View Our Latest Stock Analysis on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines